China Medical System Holdings Limited (SGX:8A8)
Singapore · Delayed Price · Currency is SGD 2.130
+0.030 (1.43%)
At close: Mar 20, 2026
SGX:8A8 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,489 | 1,620 | 2,401 | 3,259 | 3,017 |
Depreciation & Amortization | 266.93 | 259.24 | 229.57 | 227.23 | 219.82 |
Other Amortization | - | - | 23.45 | - | - |
Loss (Gain) From Sale of Assets | - | -0.5 | 0.27 | 0.4 | 0.23 |
Asset Writedown & Restructuring Costs | - | 1.15 | 171.49 | 62 | 20 |
Loss (Gain) From Sale of Investments | - | 109.03 | 60.75 | -150.01 | -115.66 |
Loss (Gain) on Equity Investments | - | -341.3 | -277.87 | -65.06 | -75.35 |
Stock-Based Compensation | - | - | -35.87 | 18.72 | 17.16 |
Provision & Write-off of Bad Debts | - | -0.5 | 52.72 | 0.11 | 1.31 |
Other Operating Activities | -997.4 | -250.21 | -125.56 | 110.79 | 5.03 |
Change in Accounts Receivable | - | -173.42 | 410.56 | 163.91 | -367.89 |
Change in Inventory | - | -130.5 | -235.77 | 8.16 | -90.87 |
Change in Accounts Payable | - | 47.82 | -82.85 | -71.86 | -33.87 |
Change in Unearned Revenue | - | 3.88 | -8.88 | -2.1 | 9.31 |
Change in Other Net Operating Assets | - | 124.08 | -80.1 | -8.04 | -112.77 |
Operating Cash Flow | 758.42 | 1,269 | 2,503 | 3,553 | 2,494 |
Operating Cash Flow Growth | -40.21% | -49.32% | -29.56% | 42.48% | -7.36% |
Capital Expenditures | -41.04 | -32.62 | -27.49 | -18.34 | -23.35 |
Sale of Property, Plant & Equipment | - | 4.09 | 0.32 | 2.32 | 3 |
Cash Acquisitions | - | - | - | -29 | -533.91 |
Divestitures | - | - | -11.16 | - | - |
Sale (Purchase) of Intangibles | -473.37 | -423.29 | -275.77 | -506.59 | -161.49 |
Investment in Securities | - | -403.8 | -470.14 | -726.06 | -898.54 |
Other Investing Activities | -469.91 | 312.75 | 341.96 | 134.27 | 126.64 |
Investing Cash Flow | -984.32 | -615.1 | -442.28 | -1,178 | -1,520 |
Long-Term Debt Issued | - | 831.3 | 1,277 | 1,375 | 1,077 |
Total Debt Issued | - | 831.3 | 1,277 | 1,375 | 1,077 |
Long-Term Debt Repaid | - | -1,296 | -1,805 | -1,445 | -11.81 |
Total Debt Repaid | - | -1,296 | -1,805 | -1,445 | -11.81 |
Net Debt Issued (Repaid) | - | -465.07 | -528.26 | -69.83 | 1,066 |
Repurchase of Common Stock | - | -238.39 | - | -48.38 | -151.52 |
Common Dividends Paid | -660.56 | -556.16 | -1,360 | -1,276 | -1,155 |
Other Financing Activities | -110.38 | -1.42 | -236.4 | -5.46 | -17.61 |
Financing Cash Flow | -770.94 | -1,261 | -2,125 | -1,400 | -258.39 |
Foreign Exchange Rate Adjustments | -8.28 | 3.04 | -0.87 | 15.51 | 1.38 |
Net Cash Flow | -1,005 | -604.56 | -65.32 | 990.64 | 717.31 |
Free Cash Flow | 717.38 | 1,236 | 2,475 | 3,535 | 2,471 |
Free Cash Flow Growth | -41.96% | -50.07% | -29.97% | 43.08% | -6.93% |
Free Cash Flow Margin | 8.74% | 16.55% | 30.89% | 38.63% | 29.63% |
Free Cash Flow Per Share | 0.30 | 0.51 | 1.01 | 1.44 | 1.00 |
Cash Interest Paid | - | 38.61 | 45.21 | 37.55 | 17.61 |
Cash Income Tax Paid | - | 538.55 | 547.05 | 450.5 | 396.73 |
Levered Free Cash Flow | 185.34 | 544.94 | 1,551 | 2,091 | 1,350 |
Unlevered Free Cash Flow | 198.03 | 569.07 | 1,580 | 2,122 | 1,368 |
Change in Working Capital | - | -128.15 | 2.97 | 90.08 | -596.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.